<DOC>
	<DOCNO>NCT00815373</DOCNO>
	<brief_summary>Both Cosopt® Xalatan® plus Timoptic® significantly low IOP , however Cosopt® demonstrate positive hemodynamic effect . The clinical significance investigate examine ophthalmic short posterior ciliary artery determine blood supply optic nerve head , site damage glaucoma</brief_summary>
	<brief_title>The Effects Cosopt® Vs Xalacom® Ocular Hemodynamics Intraocular Pressure ( IOP ) Primary Open-angle Glaucoma ( POAG )</brief_title>
	<detailed_description>Background Rationale Apoptosis retinal ganglion cell consider plausible pathogenic mechanism glaucoma . Apoptosis cause neurotrophic factor withdrawal glutamate release trigger elevated intraocular pressure ( IOP ) ischemia simultaneously separately . The topical carbonic anhydrase inhibitor , Dorzolamide ( Trusopt* ) , recently approve chronic use treatment glaucoma . The ocular hypotensive effect topical carbonic anhydrase inhibitor seem likely produce result *-adrenergic antagonist . Systemic carbonic anhydrase inhibitor know vasodilatory effect ( Maren,1987 ) . Rassam S.M.B. , Patel V. Kohner E.M. ( 1993 ) conclude acetazolamide cause increase retinal blood flow human retinal circulation . It also demonstrate Trusopt* increase retinal circulation measure scan laser ophthalmoscopy ( SLO ) ( Harris , Arend , Martin , 1996 ) . Furthermore , Trusopt increase arteriovenous passage ( AVP ) time improve contrast sensitivity normal tension glaucoma patient ( Harris , 1999 ) . Cosopt* ( dorzolamide hydrochloride-timolol maleate ophthalmic solution ) combination topical carbonic anhydrase inhibitor topical beta-adrenergic receptor block agent . Each two component reduce intraocular pressure . The IOP-reducing effect Cosopt b.i.d . great ( 1-3 mm Hg ) monotherapy either 2.0 % dorzolamide t.i.d . 0.5 % timolol b.i.d . The IOP-lowering effect Cosopt* b.i.d . approximately 1 mm Hg less concomitant therapy 2.0 % dorzolamide t.i.d . 0.5 % timolol b.i.d . A previous study show retinal circulation ( AVP time ) significantly accelerate replace Timoptic* Cosopt* glaucoma patient ( Harris , 1999 ) . Latanoprost ( Xalatan* ) prostaglandin F2* analogue believe reduce IOP increase outflow aqueous humor . The retinal vascular effect Latanoprost , however , remain unclear . While study show PGF2* induce constriction bovine isolate aqueous vein ( Nielsen 1996 ) , study unable demonstrate effect retrobulbar flow velocity ( Drance 1996 ) . It possible vasoconstrictive property drug may produce negative impact previously ischemic retinal tissue best change . In recent study compare Trusopt® Xalatan® encourage result emerge , AVP time significantly reduce Trusopt® , Xalatan® despite fact Xalatan® increase perfusion pressure ( due IOP ) Trusopt® . This strong evidence far pressure independent effect Trusopt® ocular blood flow . Objectives - To compare IOP efficacy Cosopt® Xalacom® IOP . - To determine perfusion pressure effect Cosopt® Xalacom® . - To determine blood flow effect two drug ophthalmic , central retinal short posterior ciliary artery , use Color Doppler Imaging ( CDI ) .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<criteria>1 . 18 year age great . 2 . Patient sign informed consent agreement . 3 . Corrected visual acuity 6/12 better : 4 . Characteristic glaucomatous visualfield loss optic nerve head damage one eye . 5 . Either IOP measurement ≥21 mmHg 3 month prior study entry IOP ≥ 21 mmHg end washout period 6 . Patient ≥1 IOP reduce agent . 1 . Past history ocular disease ( OAG / Cataract / Refractive error ) . 2 . Past history orbital/ocular surgery trauma . 3 . Receiving ≥ 3 IOP reduce agent . 4 . Receiving agent know produce significant cardiovascular , respiratory , renal hepatic side effect . 5 . Personal history respiratory disease asthma , emphysema chronic obstructive pulmonary disease . 6 . Personal history congestive heart failure . 7 . Personal history bradycardia 2nd 3rd degree AV block . 8 . Known allergy sulfa . 9 . Women pregnant nursing . 10 . Women child bear age planning become pregnant within one month study completion . 11 . Receiving Levitra , Viagra , Cialis erectile dysfunction drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Ocular Blood flow</keyword>
	<keyword>Ocular hypertension</keyword>
	<keyword>POAG</keyword>
	<keyword>Ocular hemodynamics</keyword>
	<keyword>Xalacom</keyword>
	<keyword>Cosopt</keyword>
</DOC>